Neuraptive Therapeutics

http://www.neuraptive.com/
Neuraptive's lead product, AxoFuse, is a therapeutic for use during peripheral nerve surgery to improve outcomes for patients. AxoFuse has been shown to improve recovery of function and sensation in traumatic injury and has potential for the same across a wide array of reconstructive surgical protocols. The US market opportunity consists of ~1.4m eligible patients annually representing a >$5B global market.
Member count: 1-10
Total raised: $12.9M

Mentions in press and media 1

DateTitleDescriptionCategoryAuthorSource
20.12.2018Neuraptive...Neuraptive Therapeutics, Inc.,...USA-finsmes.co...